“Tremendously exciting” news of cabotegravir long-acting injectable for PrEP shared at AIDS 2020

Final results of the HPTN 083 study show that for men who have sex with men and transgender women, a cabotegravir injection provided highly effective HIV prevention when given once every two months.

As support for safe consumption spaces in San Francisco grows, we urge the California Legislature to pass AB 362, which would allow San Francisco and Oakland to pilot safe consumption spaces.

At AIDS 2020, San Francisco AIDS Foundation presented positive findings from one of the largest pre-exposure prophylaxis (PrEP) 2-1-1 adherence and effectiveness studies to date.

San Francisco AIDS Foundation shared information about the incredible impact of our programs, services and research during AIDS 2020. See what we shared at the conference.

There are a variety of free programs that can help people afford medications and care even if they don’t have insurance. Read on for advice from Reina Hernandez, a PrEP benefits and HIV linkage manager from San Francisco

New research finds that 1 in 13 people experienced viral rebound after becoming undetectable, with disparities related to race, housing status, age, and more.

Andrew Jolivette, PhD, calls on the queer community to truly center Black and Indigenous queer, trans and Two-Spirit people in solidarity and kinship.

As we commemorate the end of slavery in the U.S., we must reckon with the continued effects of white supremacy, racism and generational trauma in our country, writes Marnika Shelton.